In the second half of this year, we look forward to sharing interim results from our recently-launched Phase 2 PUMA study of PROHEMA in adult patients with hematologic malignancies and to initiating a clinical trial of PROHEMA in pediatric patients with certain forms of lysosomal storage disorders," commented .
http://ift.tt/1kYuw9T
http://ift.tt/1kYuw9T
No comments:
Post a Comment